Page 68 - rcv31n3.vp

Guía sobre doble antiagregación plaquetaria en pacientes con enfermedad coronaria Revista Uruguaya de Cardiología
Óscar Bazzino Volumen 31 | nº 3 | Diciembre 2016

17. Fihn SD, Blankenship JC, Alexander KP, Bittl use and long-term clinical outcomes after drug-eluting
JA, Byrne JG, Fletcher BJ, et al. 2014 ACC/AHA/ stent implantation. JAMA. 2007;297(9281):159-68.
AATS/PCNA/SCAI/STSfocusedupdateoftheguideline
24. Grines CL, Bonow RO, Casey DE, et al. Preven-
for the diagnosis and management of patients with sta-
tion of premature discontinuation of dual antiplate-
ble ischemic heart disease: a report of theAmerican Co-
let therapy in patients with coronary artery stents: a
llege of Cardiology/American Heart Association Task
science advisory from the American Heart Associa-
Force on Practice Guidelines, and theAmerican Asso-
tion, American Collegeof Cardiology, Society for Car-
ciation for Thoracic Surgery, Preventive Cardiovascu-
diovascular Angiography and Interventions, Ameri-
lar Nurses Association, Society forCardiovascular
can College of Surgeons, and American Dental Asso-
Angiography and Interventions, and Society of Thora-
ciation, with representation from the American Co-
cicSurgeons. J Am Coll Cardiol 2014;64(18):1929-49.
llege of Physicians. Circulation 2007;115(6):813-8.
doi: 10.1016/j.jacc.2014.07.017.
25. Pfisterer M, Brunner-La Rocca HP, Buser PT,
18. Fihn SD, Gardin JM, Abrams J, Berra K, Blan-
Gardner TJ, Lockhart PB, Moliterno DJ, et al.
kenship JC, Dallas AP, et al. 2012 ACCF/AHA/
Late clinical events after clopidogrel discontinuation
ACP/AATS/PCNA/SCAI/STS guideline for the diag-
maylimit the benefit of drug-eluting stents: an obser-
nosisand management of patients with stable ische-
vational study of drug-eluting versus bare-metal
mic heart disease: a report of the American College of
stents. J Am Coll Cardiol 2006;48:2584-91.
CardiologyFoundation/American Heart Association
Task Force on Practice Guidelines, and the American 26. Navarese EP, Tandjung K, Claessen B,
College of Physicians, American Association for Tho- Andreotti F, Kowalewski M, Kandzari DE, et
racic Surgery, Preventive Cardiovascular Nurses al. Safety and efficacy outcomes of first and second
Association, Societyfor Cardiovascular Angiography generation durablepolymer drug eluting stents and
and Interventions, and Society of Thoracic Surgeons. biodegradable polymer biolimus eluting stents in cli-
J Am Coll Cardiol.2012;60(24):e44-164. nical practice: comprehensivenetwork meta-analy-
doi: 10.1016/j.jacc.2012.07.013. sis. BMJ. 2013;347:f6530. doi: 10.1136/bmj.f6530
19. O’Gara PT, Kushner FG, Ascheim DD, Casey 27. Brar SS, Kim J, Brar SK, Zadegan R, Ree M,
DE Jr, Chung MK, de Lemos JA, et al. 2013 Liu IL, et al. Long-term outcomes by clopidogrel du-
ACCF/AHA guideline for the management of ST-ele- ration and stent type in a diabetic populationwith de
vationmyocardial infarction: a report of the Ameri- novo coronary artery lesions. J Am Coll Cardiol.
can College of Cardiology Foundation/American 2008;51(23):2220-7. doi: 10.1016/j.jacc.2008.01.063.
Heart AssociationTask Force on Practice Guidelines.
28. Palmerini T, Sangiorgi D, Valgimigli M, Bion-
J Am Coll Cardiol. 2013;61(4):e78-140. doi:
di-Zoccai G, Feres F, Abizaid A, et al. Short- ver-
10.1016/j.jacc.2012.11.019.
sus long-term dual antiplatelet therapy after
20. Amsterdam EA, Wenger NK, Brindis RG, Casey drug-elutingstent implantation: an individual pa-
DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 tient data pairwise and network meta-analysis. J Am
AHA/ACC guideline for the management of patients Coll Cardiol.2015;65(11):1092-102.
withnon-ST-elevation acute coronary syndromes: a doi: 10.1016/j.jacc.2014.12.046.
report of the American College of Cardiology/Ameri-
29. Palmerini T, Benedetto U, Bacchi-Reggiani L,
can Heart Association Task Force on Practice Guide-
Biondi-Zoccai G, Feres F, et al. Mortality in pa-
lines. J Am Coll Cardiol. 2014;64(24):e139-228. doi:
tients treated with extended duration dualantiplate-
10.1016/j.jacc.2014.09.017.
let therapy after drug-eluting stent implantation: a
21. Fleisher LA, Fleischmann KE, Auerbach AD, pairwise and Bayesian network meta-analysis ofran-
Barnason SA, Beckman JA, Bozkurt B, et al. domised trials. Lancet 2015;385(9985):2371-82.
2014 ACC/AHA guideline on perioperative cardio- doi: 10.1016/S0140-6736(15)60263-X
vascular evaluation and management of patients un-
30. Giustino G, Baber U, Sartori S, Mehran R, Mas-
dergoing non cardiac surgery: a report of the Ameri-
toris I, Kini AS, et al. Duration of dual antiplatelet
can College of Cardiology/American Heart Associa-
therapy after drug-eluting stent implantation: asyste-
tion Task Force on Practice Guidelines. J Am Coll
matic review and meta-analysis of randomized contro-
Cardiol. 2014;64(22):e77-137.
lled trials. J Am Coll Cardiol. 2015; 65(13):1298-310.
doi: 10.1016/j.jacc.2014.07.944.
doi: 10.1016/j.jacc.2015.01.039.
22. Mehta SR, Yusuf S, Peters RJ, et al. Effects of
31. Navarese EP, Andreotti F, Schulze V, Ko³od-
pretreatment with clopidogrel and aspirin followed
ziejczak M, Buffon A, Brouwer M, et al. Optimal
by long-termtherapy in patients undergoing percuta-
duration of dual antiplatelet therapy after percuta-
neous coronary intervention: the PCI-CURE study.
neouscoronary intervention with drug eluting
Lancet. 2001;358:527-33.
stents: meta-analysis of randomised controlled
23. Eisenstein EL, Anstrom KJ, Kong DF, Bertrand trials. BMJ.2015;350:h1618.
ME, Lewis BS, Natarajan MK, et al. Clopidogrel doi: 10.1136/bmj.h1618.
424